Maternal Serum S100-B, PAPP-A and IL-6 levels in severe preeclampsia

dc.contributor.authorArtunc-Ulkumen, B
dc.contributor.authorGuvenc, Y
dc.contributor.authorGoker, A
dc.contributor.authorGozukara, C
dc.date.accessioned2024-07-18T11:46:20Z
dc.date.available2024-07-18T11:46:20Z
dc.description.abstractAim We aimed to investigate the relationship of maternal serum levels of S100-B, PAPP-A and IL-6 with severe preeclampsia. Materials and methods This prospective case-control study consisted of 27 severe preeclamptic and 36 healthy singleton pregnancies. The groups were matched for parity, maternal age and body mass index. Maternal blood sampling for S100B, PAPP-A and IL-6 was performed at the morning after an overnight fasting. Results S100-B concentrations were significantly higher in severe preeclampsia group (0.09 +/- 0.05 vs. 0.13 +/- 0.01 lg/L; p = 0.025). PAPP-A levels were higher (196.54 +/- 21.56 vs. 208.80 +/- 23.97 mIU/ml; p = 0.707) and IL-6 levels were lower in severe preeclamptic group (68.79 +/- 29.89 vs. 37.30 +/- 6.46 pg/ml; p = 0.372). AUC value for S100-B was calculated as 0.712. When cutoff level for serum S100-B for predicting severe preeclampsia was regarded as 0.0975 lg/L, sensitivity and specificity were found to be 81.4 % and 58.3 %, respectively. Pregnancies with C0.0975 lg/L S100-B levels had 12.75-fold increased risk for having CNS symptoms (OR 12.75; 95 % CI 2.69-60.28) and 3.27-fold increased risk for having HELLP syndrome (OR 3.27; 95 % CI 0.62-17.36). Conclusion Our results suggest that serum S100B levels may be a potential marker in severe preeclampsia for the severity of hypoperfusion both in placenta and brain pointing at subsequent risk of organ failure.
dc.identifier.issn0932-0067
dc.identifier.other1432-0711
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/2660
dc.language.isoEnglish
dc.publisherSPRINGER HEIDELBERG
dc.subjectPLASMA-PROTEIN-A
dc.subjectNORMAL PREGNANCIES
dc.subjectINTERLEUKIN-6
dc.subjectBIRTH
dc.subjectRISK
dc.subjectBLOOD
dc.subjectWOMEN
dc.titleMaternal Serum S100-B, PAPP-A and IL-6 levels in severe preeclampsia
dc.typeArticle

Files